Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study

M.L.J. Smits; J.F.W Nijsen; M.A.A.J. van den Bosch; M.G.E.H. Lam; M.A.D. Vente; W.P.T.M. Mali; A.D. van het Schip; B.A. Zonnenberg

Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study

Translated title of the contribution: Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study

M.L.J. Smits, J.F.W Nijsen, M.A.A.J. van den Bosch, M.G.E.H. Lam, M.A.D. Vente, W.P.T.M. Mali, A.D. van het Schip, B.A. Zonnenberg

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study
Original language	Undefined/Unknown
Pages (from-to)	1025-1034
Number of pages	10
Journal	LANCET ONCOLOGY
Volume	13
Issue number	10
Publication status	Published - 2012

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/22920685

Cite this

Smits, M. L. J., Nijsen, J. F. W., van den Bosch, M. A. A. J., Lam, M. G. E. H., Vente, M. A. D., Mali, W. P. T. M., van het Schip, A. D., & Zonnenberg, B. A. (2012). Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study. LANCET ONCOLOGY, 13(10), 1025-1034. http://www.ncbi.nlm.nih.gov/pubmed/22920685

@article{a23ffe0a1fb040c9ad0008200fb4b987,

title = "Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "M.L.J. Smits and J.F.W Nijsen and {van den Bosch}, M.A.A.J. and M.G.E.H. Lam and M.A.D. Vente and W.P.T.M. Mali and {van het Schip}, A.D. and B.A. Zonnenberg",

year = "2012",

language = "Undefined/Unknown",

volume = "13",

pages = "1025--1034",

journal = "LANCET ONCOLOGY",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "10",

}

TY - JOUR

T1 - Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study

AU - Smits, M.L.J.

AU - Nijsen, J.F.W

AU - van den Bosch, M.A.A.J.

AU - Lam, M.G.E.H.

AU - Vente, M.A.D.

AU - Mali, W.P.T.M.

AU - van het Schip, A.D.

AU - Zonnenberg, B.A.

PY - 2012

Y1 - 2012

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 1470-2045

VL - 13

SP - 1025

EP - 1034

JO - LANCET ONCOLOGY

JF - LANCET ONCOLOGY

IS - 10

ER -